FindTrial
Sign In

Transurethral surgery of prostate: efficacy comparison

Comparison of Various Laser Vaporesection versus Plasmakinetic Resection for Treatment of Benign Prostate Obstruction

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900021449
Enrollment
Unknown
Registered
2019-02-21
Start date
2016-01-01
Completion date
Unknown
Last updated
2019-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate

Interventions

1:transurethral resection of prostate with monopolar electocautery (TURP)
2:plasmakinetic resection of the prostate (PKRP)
3:multipulse laser vaporesection of the prostate (MPVP)
4:greenlight laser vaporesection of the prostate (GRP)
5:thulium laser resection of the prostate (ThuRP)
6:diode laser vaporesection of the prostate (DRP)

Sponsors

Department of Urology
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
50 Years to 98 Years

Inclusion criteria

Inclusion criteria: patient aged older than 50 years, maximum flow rate (Qmax) < 15 mL/second and the International Prostate Symptom Score (IPSS) = 10. All subjects received quality-of-life questionnaire (QoL) and transrectal ultrasound of the prostate (TRUS) preoperatively.

Exclusion criteria

Exclusion criteria: Patients with prostate cancer, bladder cancer, previous transurethral surgery, interstitial cystitis and neurogenic bladder were excluded.

Design outcomes

Secondary

MeasureTime frame
Maximal uroflowrate;—

Primary

MeasureTime frame
IPSS;—

Countries

China

Contacts

Public ContactFu-Shun, Hsu

New Taipei City Hospital

fs_hsu@outlook.com+886 921566304

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026